Single ascending doses
Showing 1 - 25 of >10,000
Alzheimer's Disease Trial (CS6253 Solution for Injection, Placebo)
Not yet recruiting
- Alzheimer's Disease
- CS6253 Solution for Injection
- Placebo
- (no location specified)
Jul 20, 2023
Safety, Pharmacokinetics, Pharmacodynamics Trial in Overland Park (Kratom, Placebo)
Recruiting
- Safety
- +2 more
- Kratom
- Placebo
-
Overland Park, KansasAltasciences Clinical Kansas, Inc.
Oct 10, 2023
Healthy Volunteers Trial (ABBV-141, Placebo for ABBV-141)
Not yet recruiting
- Healthy Volunteers
- ABBV-141
- Placebo for ABBV-141
- (no location specified)
Nov 20, 2023
Parkinson Disease Trial in Turku (HER-096, Placebo)
Recruiting
- Parkinson Disease
- HER-096
- Placebo
-
Turku, FinlandClinical Research Services Turku - CRST Oy
Jun 13, 2023
Von Willebrand Diseases Trial in Vienna (VGA039, Placebo)
Recruiting
- Von Willebrand Diseases
- VGA039
- Placebo
-
Vienna, AustriaMedical University of Vienna
Mar 20, 2023
Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending
Not yet recruiting
- Bladder Cancer
- APL-1202 and APL-1501 (Single ascending dose)
- APL-1202 and APL-1501 (Multiple Ascending dose)
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Sep 11, 2023
Hepatitis B, Chronic Trial in Jilin (AHB-137 injection, Placebo)
Recruiting
- Hepatitis B, Chronic
- AHB-137 injection
- Placebo
-
Jilin, ChinaThe First Hospital of Jilin University
Nov 2, 2023
Lumbosacral Radiculopathy Trial in Salt Lake City (KLS-2031, Placebo)
Active, not recruiting
- Lumbosacral Radiculopathy
- KLS-2031
- Placebo
-
Salt Lake City, UtahKolon Investigative Site
Oct 5, 2022
Healthy Volunteer Trial in Leeds (REGN7508 (IV), REGN7508 (SC), Matching Placebo (IV))
Recruiting
- Healthy Volunteer
- REGN7508 (IV)
- +3 more
-
Leeds, United KingdomLabcorp Clinical Research Unit
Jan 30, 2023
Pain, Inflammatory, Pain, Neuropathic Trial (AFA-281)
Not yet recruiting
- Pain, Inflammatory
- Pain, Neuropathic
- (no location specified)
Sep 22, 2022
IPF Trial (HNC1058 Capsules)
Not yet recruiting
- IPF
- HNC1058 Capsules
- (no location specified)
Apr 5, 2023
Neovascular Age-related Macular Degeneration (nAMD) Trial in Abilene (OCU-10-C-110 for Injection)
Not yet recruiting
- Neovascular Age-related Macular Degeneration (nAMD)
- OCU-10-C-110 for Injection
-
Abilene, TexasRetina Research Institute of Texas
Jun 6, 2023
Pulmonary Arterial Hypertension Trial in Adelaide (L608 Inhalation Solution, Placebo solution)
Not yet recruiting
- Pulmonary Arterial Hypertension
- L608 Inhalation Solution
- Placebo solution
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Jul 12, 2023
Pulmonary Disease, Chronic Obstructive Trial in Cambridge (GSK3862995B, Placebo)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- GSK3862995B
- Placebo
-
Cambridge, United KingdomGSK Investigational Site
Nov 26, 2023
Healthy Volunteers Trial (REGN7544, Matching Placebo)
Not yet recruiting
- Healthy Volunteers
- REGN7544
- Matching Placebo
- (no location specified)
Jul 24, 2023
Healthy Volunteers Trial in Copenhagen (AP31969, Placebo)
Not yet recruiting
- Healthy Volunteers
- AP31969
- Placebo
-
Copenhagen, DenmarkAcesion Pharma
Sep 27, 2023
Chronic Hepatitis B Trial in Grafton (AHB-137 injection, Placebo)
Not yet recruiting
- Chronic Hepatitis B
- AHB-137 injection
- Placebo
-
Grafton, Auckland, New ZealandNew Zealand Clinical Research
Jan 29, 2023
Healthy Volunteers, Mild to Moderate Psoriasis Trial in Manchester (Placebo, AX-202)
Recruiting
- Healthy Volunteers
- Mild to Moderate Psoriasis
- Placebo
- AX-202
-
Manchester, Wythenshawe, United KingdomMedicines Evaluation Unit
Jul 19, 2023
HIV-1-infection Trial in Los Angeles (Elsulfavirine)
Recruiting
- HIV-1-infection
-
Los Angeles, CaliforniaAltasciences Clinical Los Angeles, Inc.
Apr 11, 2022
